Biopharmaceutical Company Issues Major Patents For For Alzheimer's Disease Treatment

ANEW MEDICAL, INC. (NASDAQ: WENA), a biotechnology company based in the United States, has announced significant advancements in its mission to develop genetic therapies aimed at combating neurodegenerative diseases. Recently, the company was granted patents in major Asian markets, specifically Hong Kong and China, for its groundbreaking genetic approaches targeting diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). $Anew Medical (WENA.US)$